Back to results
US 2014/0213561 A1Published application
Ophthalmic suspension for ocular use
AssigneeAllergan, Inc.
InventorKothanda Raman T. RAJAN
Life of this patent
Estimating the term…
Abstract
A gatifloxacin and prednisolone topical ophthalmic pharmaceutical compositions for prevention and treatment of ophthalmic bacterial infections and inflammatory conditions associated with pre-surgical and/or post surgical ocular surgeries.
Claims14
A topical ophthalmic composition for treating ophthalmic bacterial infections in a human patient wherein the ophthalmic composition comprising gatifloxacin and prednisolone.
Dependencies are inferred from the claim text.